IC 016. US 002 005 022 023 029 037 038 050. G & S: Printed informational and educational materials, namely, booklets and reference guides, in the field of Alpha-1 Antitrypsin Deficiency. FIRST USE: 19950400. FIRST USE IN COMMERCE: 19950400

IC 036. US 100 101 102. G & S: Charitable services, namely, providing financial support for clinical research to improve the lives of individuals affected by Alpha-1 Antitrypsin Deficiency. FIRST USE: 19950400. FIRST USE IN COMMERCE: 19950400

IC 041. US 100 101 107. G & S: Education services, namely, providing classes, seminars, and workshops in the field Alpha-1 Antitrypsin Deficiency; providing on-line publications in the nature of guides and newsletters in the field of Alpha-1 Antitrypsin Deficiency; training of study staff in the field of Alpha-1 Antitrypsin Deficiency and clinical trials. FIRST USE: 19970100. FIRST USE IN COMMERCE: 19970100

IC 042. US 100 101. G & S: Providing medical and scientific research information in the field of Alpha-1 Antitrypsin Deficiency; consultation services in the field of facilitating and conducting clinical trials involving human subjects of new treatment options for individuals affected by Alpha-1 Antitrypsin Deficiency in the nature of identifying qualified study sites and researchers and encouraging study enrollment; providing quality assurance services in the field of clinical trials by generating and monitoring study data and documentation thereof for quality assurance purposes. FIRST USE: 19950400. FIRST USE IN COMMERCE: 19950400

IC 044. US 100 101. G & S: Health care services, namely, disease management for individuals affected by Alpha-1 Antitrypsin Deficiency; providing support and assistance services to inform individuals affected by Alpha-1 Antitrypsin Deficiency about the range of possible diagnoses and therapies to improve the quality of their lives; providing links to the web sites of others featuring information about the diagnosis, management and treatment of Alpha-1 Antitrypsin Deficiency; providing health and medical care information to individuals affected by Alpha-1 Antitrypsin Deficiency about the range of possible diagnoses and therapies to improve the quality of their lives; Providing support and assistance in the nature of health and wellness counseling to individuals affected by Alpha-1 Antitrypsin Deficiency. FIRST USE: 19950400. FIRST USE IN COMMERCE: 19950400

IC 045. US 100 101. G & S: *Providing support and assistance in the nature of counseling to individuals affected by Alpha-1 Antitrypsin Deficiency;* Identifying qualified study sites, namely, inspection of laboratory research facilities for safety purposes. FIRST USE: 20000500. FIRST USE IN COMMERCE: 20000500